Petra Jungmayr: Zielgerichtet gegen Migräne. In: DAZ.online. 12. Juli 2018 (deutsche-apotheker-zeitung.de [abgerufen am 25. September 2018]).
doi.org
SJ Tepper, MJ Stillman: Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine. In: Headache. Vol. 48, Nr.8, Dezember 2008, S.1259–1268, doi:10.1111/j.1526-4610.2008.01214.x.
Lanfranco Pellesi, Simona Guerzoni, Luigi Alberto Pini: Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date. In: Clinical Pharmacology in Drug Development. Band6, Nr.6, 2017, S.534–547, doi:10.1002/cpdd.345, PMID 28409893, PMC 5697612 (freier Volltext).
Philip R. Holland, Peter J. Goadsby: Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy. In: Neurotherapeutics. Band15, Nr.2, April 2018, S.304–312, doi:10.1007/s13311-018-0617-4, PMID 29556965, PMC 5935646 (freier Volltext).
nih.gov
ncbi.nlm.nih.gov
Lanfranco Pellesi, Simona Guerzoni, Luigi Alberto Pini: Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date. In: Clinical Pharmacology in Drug Development. Band6, Nr.6, 2017, S.534–547, doi:10.1002/cpdd.345, PMID 28409893, PMC 5697612 (freier Volltext).
Philip R. Holland, Peter J. Goadsby: Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy. In: Neurotherapeutics. Band15, Nr.2, April 2018, S.304–312, doi:10.1007/s13311-018-0617-4, PMID 29556965, PMC 5935646 (freier Volltext).